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Background: The anatomical status of the pancreatic remnant following a 
pancreatic head resection varies greatly among patients. The aim of this study 
was to improve management of the pancreatic remnant for reducing pancreatic 
fistula after pancreatic head resection. 
Methods: Ninety-five consecutive patients who underwent an end-to-side, 
duct-to-mucosa pancreaticojejunostomy after pancreatic head resection were 
included in the study. To approximate the pancreatic stump to the jejunum, the 
transfixing and interrupted suture techniques were used in 51 and 44 patients, 
respectively. We modified the interrupted suture technique according to the 
anatomical status of the pancreatic remnant, i.e., the shape of the pancreatic 
stump and the location of the pancreatic duct.  
Results: There was no operative mortality in this study. Overall, 14 patients 
(15%) developed a clinically relevant pancreatic fistula. Certain anatomical 
features, including a small pancreatic duct, a soft, nonfibrotic pancreatic gland, 
and a pancreatic duct adjacent to the posterior cut edge, were significantly 
associated with pancreatic fistula. The fistula rate in the interrupted suture 
group was 7%, lower than that (22%) in the transfixing suture group (p=0.036), 
and was not influenced by pancreatic anatomy. Multivariate analysis identified 
a nonfibrotic pancreas (versus fibrotic pancreas; odds ratio [OR] 12.58, 95% CI 
1.2-23.9, p=0.001), a soft pancreas (versus hard pancreas; OR 4.67, CI 1.2-51.1, 
p=0.006), and the transfixing suture technique (versus interrupted suture 
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technique; OR 9.91, CI 1.7-57.5, p=0.003) as significant predictors of clinically 
relevant pancreatic fistula. 
Conclusions: Pancreatic anastomosis modified according to the pancreatic 
anatomy is effective in reducing the risk of pancreatic fistula formation with 





Significant advances in surgical techniques and critical care 
management have substantially reduced the mortality of pancreatic surgery. 
However, morbidity remains considerably high even in high-volume centers, 
approaching 40% to 50%, and pancreatic fistula still accounts for the majority 
of surgical complications following pancreatic head resection.1-4 
Various risk factors for pancreatic fistula after pancreatic head 
resection have been identified, including advanced age,5 duration of jaundice,6 
creatinine clearance,6 ampullary disease,3,4,7,8 prolonged operations,5,7 and 
intraoperative blood loss.5-7 The most generally accepted determinants of 
postoperative pancreatic fistula are the size of the pancreatic duct3,8-10 and the 
consistency of the pancreatic remnant.2,5,7,9,10 Despite the more than 80 different 
methods of pancreaticoenteric anastomosis that have been proposed for the 
prevention of pancreatic fistula, management of the pancreatic remnant after 
pancreatic head resection still remains a challenge because of the lack of a gold 
standard for all patients.11  
The anatomical features of the stump of the pancreatic remnant 
following a pancreatic head resection vary greatly among patients, making it 
difficult to perform a safe pancreaticoenteric anastomosis in the same manner 
for all patients. In this study, we examined in detail the anatomical status of the 
pancreatic stump, including the actual thickness and width of the gland and the 
location of the main pancreatic duct, as well as the pancreatic duct size and 
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gland consistency, in patients undergoing a pancreatic head resection. Then we 
evaluated the risk factors, including the remnant pancreatic anatomy, for 
postoperative pancreatic fistula. Moreover, we investigated the efficacy of 
modifying the pancreatic anastomosis technique according to the anatomical 
conditions of each pancreatic remnant to reduce the risk of pancreatic fistula 
development.  
 
Patients and Methods 
 
A total of 95 consecutive patients who underwent an end-to-side, 
duct-to-mucosa pancreaticojejunostomy after pancreatic head resection, 
between January 2002 and August 2008, were included in the study (Table 1). 
There were 51 men and 44 women with a mean age of 69 (range 38-86) years. 
Pancreatic head resection was achieved by a pylorus-preserving 
pancreaticoduodenectomy (PPPD; n=66), standard pancreaticoduodenectomy 
(PD; n=15), pancreatic head resection with segmental duodenectomy (PHRSD; 
n=9) or duodenum-preserving total pancreas head resection (DPPHR; n=5). The 
pathological conditions included intraductal papillary mucinous neoplasms of 
the pancreas (n=29), pancreatic ductal adenocarcinomas (n=27), bile duct 
carcinomas (n=21), ampullary carcinomas (n=7), chronic pancreatitis (n=4), 
pancreatic endocrine tumors (n=2), solid pseudopapillary tumors of the 
pancreas (n=2), gallbladder carcinomas (n=2), and gastric carcinoma (n=1). 
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Surgical Procedures of Pancreaticojejunostomy 
 Pancreaticojejunostomy was achieved by a double-layer method in all 
patients, consisting of a duct-to-mucosa anastomosis for the inner layer and an 
approximation between the pancreatic stump and the jejunum for the outer layer. 
To construct duct-to-mucosa anastomosis, a small incision with the same 
diameter as the pancreatic duct was made on the antimesenteric side of the 
jejunal limb, and anastomosis was performed between the pancreatic duct and 
the entire jejunal wall, with 6 to 10 interrupted sutures using a 5-0 or 6-0 
polydioxanone stitch (PDSII; Ethicon, inc, Somerville, NJ). For approximating 
the pancreatic stump to the jejunum, the transfixing suture technique described 
by Kakita et al.12 as “one-layer suturing” was used in 51 patients, with 6 to 8 
sutures using a 4-0 polypropylene stitch (Prolene; Ethicon, Inc, Somerville, NJ), 
while the interrupted suture technique was employed in the remaining 44 
patients, with 12 to 16 sutures using a 4-0 Prolene stitch.  
In the transfixing suture technique, the sutures for the outer layer were 
inserted from the anterior surface of the pancreatic remnant and introduced 
straight through the pancreatic parenchyma to the posterior surface (Figure 1). 
The sutures then lifted the seromuscular layer of the jejunum widely enough to 
cover the pancreatic stump.12 In the interrupted suture technique, the manner of 
outer-layer suturing was modified according to the anatomical status of the 
pancreatic remnant, i.e., the shape of the pancreatic stump and the location of 
the pancreatic duct (Figure 2), to achieve a tension-free approximation and also 
leave no dead space between the pancreatic stump and the jejunal wall. In 
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patients with a round or an oval-shaped pancreatic stump (n=13), the sutures 
were arranged circumferentially around the pancreatic duct in a radial fashion 
(Figure 3a), such that the stitches were inserted from the pancreatic cut surface 
close to the inner suture line and introduced to the posterior surface for the 
posterior outer row of sutures, beginning at the posterior corner. For the 
placement of the anterior outer row of sutures, the stitches were inserted from 
the anterior pancreatic capsule and introduced close to the inner suture line. The 
sutures then picked up the seromuscular layer of the jejunum with the same 
radial arrangement (Figure 3b). In patients with a flat-shaped pancreatic stump 
(n=31), the sutures were placed perpendicularly to the major axis of the 
pancreatic stump with a parallel arrangement of sutures for both the anterior 
and posterior rows (Figure 4). If the pancreatic duct was located close to the 
posterior cut edge of the pancreatic stump within a distance of 4 mm (n=24), 
the first and second stitches for the posterior outer row of sutures were inserted 
close to the cephalic and caudal corner of the inner suture line, regardless of the 
shape of the pancreatic stump, and then penetrated to the posterior surface just 
below the pancreatic duct (Figure 5).  
The pancreaticojejunostomy was performed by 5 different surgeons, 2 
with more than 15 years and 3 with less than 15 years of surgical practice. An 
external pancreatic duct stent was placed in 61 patients. No sealants were 
employed in any patients. Two drains were routinely placed close to the ventral 
side of pancreatic anastomosis for peritoneal drainage in each patient. 
Detailed Data Recording 
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Preoperative data obtained included the age, gender, history of 
jaundice, serum levels of albumin, total bilirubin and hemoglobin, lymphocyte 
counts, creatinine clearance, oral glucose tolerance test (OGTT), hemoglobin 
A1c (HbA1c) levels, N-benzoyl-L-tyrosyl-p-aminobenzoic acid (BT-PABA) 
test, profiles of the time-signal intensity curve (TIC) of the pancreas on 
dynamic contrast-enhanced magnetic resonance imaging (MRI), and primary 
disease pathology. Pancreatic TICs were obtained prior to surgery using a 1.5-T 
superconducting MRI system with a region of interest placed at the proposed 
transection line for the pancreas and were classified into 3 types: type I, 
characterized by a rapid rise to a peak followed by a rapid decline, indicating a 
normal pancreas without fibrosis; and types II and III with a slow rise to a peak 
followed by a slow decline or plateau, indicating a fibrotic pancreas.13  
The intraoperative variables included texture of the pancreatic gland, 
diameter of the pancreatic duct (≤3mm, >3mm), thickness and width of the 
pancreas measured at the pancreatic stump, location of the pancreatic duct, type 
of pancreatic resection (PPPD, PD, PHRSD, or DPPHR), lymphadenectomy 
(non, regional, or extended), the outer-layer suturing technique for a 
pancreaticojejunostomy (transfixing suture or interrupted suture), use of a 
pancreatic stent, operative time, intraoperative blood loss, blood transfusion 
(with or without) and surgeon experience (<15yrs, ≥15yrs). The texture of the 
pancreas at the pancreatic stump was classified by the operating surgeon as soft 
(normal, friable), intermediate, or hard (fibrotic, sclerotic). The location of the 
pancreatic duct was evaluated at the pancreatic cut end by measuring the 
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distance between the pancreatic duct and the cut edge of the pancreas in 4 
directions, i.e., toward the anterior, posterior, superior, and inferior cut edges 
(Figure 6). 
Study End Point 
The end point of the primary study was postoperative pancreatic fistula. 
Based on the International Study Group for Pancreatic Fistula (ISGPF) clinical 
criteria,14 pancreatic fistula was defined as the output via an operatively placed 
drain of any measurable volume of drain fluid on or after postoperative day 5, 
associated with an elevated amylase content greater than 3 times the upper limit 
of the normal serum amylase value (>390 IU/L). The severity of pancreatic 
fistula was classified into 3 grades as follows: grade A fistulas are transient, 
asymptomatic fistulas with only elevated drain amylase levels, for which 
treatments or deviation in clinical management are not required; grade B 
fistulas are clinically apparent, symptomatic fistulas that require diagnostic 
evaluation and therapeutic management; and grade C fistulas are severe, 
clinically significant fistulas that require major deviations in clinical 
management and aggressive therapeutic interventions. 
Statistical Analyses 
In strict accordance with the ISGPF classification scheme, the patients 
were divided into 2 groups, as patients who lacked clinical evidence of fistula 
(no fistula or grade A fistula) and patients with a clinically relevant pancreatic 
fistula (grade B or C). The aforementioned 13 preoperative and 13 
intraoperative parameters were registered as presumed risk factors for 
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pancreatic fistula. The groups were initially compared using standard univariate 
statistical tests (chi-square test, two-tailed Fisher’s exact test, and 
Mann-Whitney’s U-test, where appropriate) to identify the variables associated 
with pancreatic fistula. Statistically significant variables were then entered into 
a multivariable logistic regression analysis to assess any independent influences 
on postoperative pancreatic fistula. Values of p<0.05 were considered to be 




Morbidity and Mortality  
There was no operative mortality in this study. Pancreatic fistula of any 
extent occurred in 20 of the 95 patients (21%). There were 6 grade A fistulas, 
12 grade B fistulas, and 2 grade C fistulas, presenting with a clinically relevant 
fistula rate of 15%. Two patients with a grade C fistula required surgical 
re-exploration for definitive management of the problem. Other major 
postoperative complications included pulmonary complications (16%), delayed 
gastric emptying (7%), wound infection (6%), ascending cholangitis (4%), 
intraabdominal abscess (3%), and biliary leakage (3%). 
Risk Factors 
A comparison of perioperative risk factors for the 2 study groups is 
shown in Table 2. Among the 13 preoperative parameters, the BT-PABA test 
result (p=0.032) and pancreatic TIC profile from dynamic MRI (p<0.001) were 
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significant predictors of a clinically relevant fistula in univariate analyses. 
Patients with normal exocrine pancreatic function were likely to develop 
pancreatic fistula. Of the 66 patients with type I pancreatic TIC, 14 patients 
(21%) demonstrated a clinically relevant pancreatic fistula, whereas none of the 
29 patients with type II or III pancreatic TIC displayed pancreatic fistula. No 
significant differences in patient age, gender, history of jaundice, or laboratory 
values including the concentrations of serum albumin, total bilirubin and 
hemoglobin, lymphocyte counts, and creatinine clearance were noted between 
the 2 patient groups. The results of OGTT and HbA1c levels had no impact on 
the occurrence of pancreatic fistula. Although a high rate of fistula was 
recognized in patients with bile duct carcinoma (19%), in comparison to 
patients with pancreatic ductal adenocarcinoma (7%) or chronic pancreatitis 
(0%), no significant differences in pathology were observed between the 2 
patient groups. 
Among the 13 intraoperative parameters, the texture of the pancreas 
(p=0.035), pancreatic duct size (p=0.023), location of the pancreatic duct (the 
distance between the pancreatic duct and the posterior cut edge of the pancreas; 
P=0.041), and the surgical procedure of pancreaticojejunostomy (p=0.037) 
were shown to be significant predictors of clinically relevant pancreatic fistula 
in univariate analyses. Patients with a soft pancreas or a small pancreatic duct 
(≤3mm) were at extremely high risk for developing pancreatic fistula. 
Interestingly, patients with a pancreatic duct located close to the posterior edge 
of the pancreatic stump were likely to develop pancreatic fistula, regardless of 
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the thickness and width of the pancreas, and 9 of the 37 patients (24%) with 
such contiguity of the pancreatic duct to the posterior cut edge (≤3mm) 
developed pancreatic fistula. On the other hand, 11 of the 51 patients (22%) 
who received the transfixing suture technique for the outer layer of 
pancreaticojejunostomy demonstrated a clinically relevant pancreatic fistula (9 
grade B fistulas and 2 grade C fistulas). Meanwhile, the fistula rate related to 
the interrupted suture technique was 7% (3 grade B fistulas and no grade C 
fistula). The type of pancreatic resection, the extent of lymphadenectomy, the 
operative time, intraoperative blood loss, the incidence of blood transfusion, 
and surgeon experience were similar for the 2 patient groups.  
A multivariable logistic regression analysis of 6 factors univariately 
associated with pancreatic fistula, i.e., BT-PABA test, pancreatic TIC, texture of 
the pancreas, pancreatic duct size, location of the pancreatic duct, and 
anastomosis technique for pancreaticojejunostomy, identified pancreatic TIC 
(type I versus types II and III; odds ratio [OR] 12.58, 95% CI 1.2-23.9, 
p=0.001), pancreatic gland consistency (soft versus hard; OR 4.67, CI 1.2-51.1, 
p=0.006), and pancreaticojejunal anastomosis technique (transfixing suture 
versus interrupted suture; OR 9.91, CI 1.7-57.5, p=0.003) as significant 
independent predictors of clinically relevant pancreatic fistula (Table 3).  
A comparison of risk factors for pancreatic fistula between the 
transfixing suture group and the interrupted suture group is shown in Table 4. 
In the transfixing suture group, univariate analyses identified the occurrence of 
pancreatic fistula to be significantly influenced by the BT-PABA test result 
 13
(p=0.033), pancreatic TIC (p=0.001), pancreatic texture (p=0.001), pancreatic 
duct size (p<0.001), and location of the pancreatic duct (p=0.001). In the 
interrupted suture group, there were no significant risk factors predisposing a 




Pancreaticoenteric anastomosis still represents the “Achilles’ heel” of 
pancreatic surgery.15 In particular, pancreatic fistula is a leading cause of 
surgical complications after pancreatic head resection and is often linked with 
prolonged hospital stay, increased costs, and mortality.16-18 The incidence of 
pancreatic fistula after pancreatic head resection ranges in the literature 
between 0% and 30%;1-4,18-21 however, the fistula rate strictly depends on the 
definition used.22 In 2005, the ISGPF developed a universal definition of 
pancreatic fistula, with a grading system able to stratify complicated patients 
into 3 groups as grades A, B and C, based on the clinical implications and costs 
of their postoperative course.14 Grade A fistula presents with an elevated drain 
amylase level only and lacks any clinical consequences, i.e., a “biochemical” 
fistula. Contrarily, grades B and C fistulas have an intermediate or a dramatic 
impact on patients, requiring therapeutic interventions. In this study, we thus 
evaluated the risks for pancreatic fistula after pancreatic head resection in 2 
different study groups, patients who lacked clinical evidence of fistula (no 
fistula or grade A fistula) and patients with a clinically relevant pancreatic 
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fistula (grade B or C fistula) in strict accordance with the ISGPF classification 
scheme.  
Pancreatic fistula of any extent occurred in 20 of the 95 
pancreatic-head-resection patients (21%) in this study, and 14 (15%) of the 
fistula cases were clinically relevant. The BT-PABA test result, pancreatic TIC 
profile, pancreatic texture, pancreatic duct size, location of the pancreatic duct, 
and surgical procedure of pancreaticojejunostomy were shown to be 
significantly associated with clinically relevant pancreatic fistula. Multivariate 
analysis identified that the pancreatic TIC, gland consistency, and 
pancreaticojejunal anastomosis technique were significant independent 
predictors of pancreatic fistula. All these risk factors, except for the 
anastomosis technique, were pancreatic anatomy-related factors; both the 
BT-PABA test results and pancreatic TIC profiles obtained from dynamic 
contrast-enhanced MRI well reflect the pancreatic anatomy, especially the 
degree of pancreatic fibrosis.13 Patients undergoing pancreatic head resection 
have been categorized grossly into 2 groups based on the anatomical status of 
the pancreatic remnant: patients with a soft, fragile pancreas or small pancreatic 
duct, who are considered at high risk for pancreatic fistula; and patients with a 
fibrotic, firm pancreas or dilated pancreatic duct, who are at low risk.2,3,5,7-10,23-25 
Our results mirrored these reported data.  
A unique result of our analysis was that the location of the pancreatic 
duct had a significant impact on a patient’s predisposition to developing 
pancreatic fistula after pancreatic head resection. Within the body and tail of the 
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pancreas, the pancreatic duct lies slightly cephalad to a line drawn midway 
between the superior and inferior edges of the pancreas, and the duct is also 
more posterior than anterior.26 In our study group the average thickness of the 
pancreatic stump and that of the pancreatic parenchyma beneath the pancreatic 
duct were 16.5 mm and 4.1 mm, respectively. Patients who had a pancreatic 
duct located close to the posterior cut edge within a distance of 3 mm were 
highly associated with pancreatic fistula, although neither the thickness/width 
of the pancreatic stump nor the distance between the pancreatic duct and the 
anterior, superior, or inferior cut edge of the pancreas had any impact on the 
development of pancreatic fistula. During double-layer pancreaticojejunal 
anastomosis, a duct-to-mucosa anastomosis can be safely applied even to a 
pancreatic duct adjacent to the posterior cut edge. However, such an anatomical 
situation of the pancreatic duct would make more difficult a safe approximation 
between the pancreatic stump and the jejunal wall, especially in its posterior 
corner, and would likely result in pancreatic fistula.  
Possible pancreatic stump management for reducing the risk of 
pancreatic fistula and subsequent septic complications after pancreatic head 
resection may involve the use of ultrasonically activated shears27 or an 
ultrasonic dissector28,29 during pancreas transection, optimizing the blood 
supply to the pancreas,30 duct-to-mucosa pancreaticoenteric anastomosis,31-34 
dunking pancreatojejunostomy,19,25,35 pancreaticogastrostomy,16,25,33,36,37 use of 
a pancreatic duct stent,38 omental wrapping of skeletonized major vessels,39,40 
or intraoperative octreotide administration via the gastroduodenal artery.41 In 
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this study, we modified the outer-layer interrupted suture technique according 
to the anatomical status of each pancreatic remnant. As a consequence, a lower 
fistula rate of 7% was achieved in this group, compared to the transfixing 
suture group with a fistula rate of 22%. In addition, the fistula rate for the 
interrupted suture technique was the same, whether it was performed on a soft 
or firm pancreas, a small or large pancreatic duct, or even to a pancreatic duct 
adjacent to the posterior cut edge. By contrast, the fistula rate was 
significantly influenced by the pancreatic anatomy in the transfixing suture 
group. Sugiyama et al.28 examined 4 patients with a soft pancreas and a small 
main pancreatic duct and indentified from 5 to 7 microscopic pancreatic ducts 
on the cut surface of the resected pancreas following a 
pancreaticoduodenectomy. We believe that the existence of small pancreatic 
ducts that are exposed on the transected pancreatic surface can lead to 
pancreatic juice leakage and, ultimately, major anastomotic leakage after a 
pancreaticoduodenectomy, and the uniform transfixing suture technique, 
rather than the interrupted suture technique which is tailored to the pancreatic 
anatomy, may therefore have the limitations in preventing leaks from small 
side branches on the pancreatic cut surface, or may even produce leaks from 
the suture injury to the main pancreatic duct itself. Although a standardized 
single approach to pancreatic anastomosis may help to reduce operative 
morbidity after pancreatic head resection,42 it is reasonable to modify the 
pancreatic anastomosis depending on the diverse intraoperative pancreatic 
scenarios because the anatomical features of the pancreatic stump vary greatly 
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among patients. In performing a double-layer pancreaticojejunostomy, we 
generally recommend a radial arrangement of the outer-layer interrupted 
sutures around the pancreatic duct for a round or an oval-shaped pancreatic 
stump, while a parallel arrangement of the sutures perpendicularly to the 
major axis of the pancreatic stump for a flat-shaped pancreatic stump. To 
achieve a close, safe approximation between the pancreatic stump and the 
jejunal wall in patients with a pancreatic duct adjacent to the posterior cut 
edge of the pancreatic stump, the first and second stitches for the posterior 
outer row of sutures should be placed close to the cephalic and caudal corner 
of the pancreatic duct, and then penetrated to the posterior surface just below 
the pancreatic duct. 
In conclusion, the presence of a small pancreatic duct, a soft pancreatic 
gland without fibrosis, a high output of pancreatic juice, and a pancreatic duct 
adjacent to the posterior cut edge increases the risk of developing a clinically 
relevant pancreatic fistula following a pancreatic head resection. Modification 
of the anastomosis technique for the approximation of the pancreatic stump to 
the jejunum according to the anatomical status of the pancreatic remnant is 
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Figure 1. The transfixing suture technique for pancreaticojejunostomy. The 
sutures for the outer layer are inserted from the anterior surface of the 
pancreatic remnant, introduced straight through the pancreatic parenchyma to 
the posterior surface, and then lifted the seromuscular layer of the jejunum. 
 
Figure 2. Anatomical variation of the pancreatic stump: (a) A round-shaped 
pancreatic stump, (b) An oval-shaped pancreatic stump, (c) A flat-shaped 
pancreatic stump, (d) A pancreatic duct adjacent to the posterior cut edge. 
 
Figure 3. The interrupted suture technique for pancreaticojejunostomy in 
patients with a round or an oval-shaped pancreatic stump. (a) The outer row of 
sutures is arranged circumferentially around the pancreatic duct in a radial 
fashion. (b) Anterior outer row of sutures between the pancreatic stump and the 
jejunal seromuscular layer in a patient with an oval-shaped pancreatic stump. 
 
Figure 4. The interrupted suture technique for pancreaticojejunostomy in 
patients with a flat-shaped pancreatic stump. (a) The outer row of sutures is 
placed perpendicularly to the major axis of the pancreatic stump in a parallel 
fashion. (b) Posterior outer row of sutures between the pancreatic stump and the 
jejunal seromuscular layer in a patient with a flat-shaped pancreatic stump. 
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Figure 5. The interrupted suture technique for pancreaticojejunostomy in 
patients with a pancreatic duct close to the posterior cut edge of the pancreatic 
stump (a). The first and second stitches for the posterior outer row of 
interrupted sutures in a patient with a pancreatic duct adjacent to the posterior 
cut edge (b). The stitches are inserted from the pancreatic cut surface close to 
the cephalic and caudal corner of the proposed inner suture line, and then 
penetrate to the posterior surface of the pancreas just below the pancreatic duct. 
A sonde is placed in the main pancreatic duct. 
 
Figure 6. Distance measurement between the pancreatic duct and the cut edge 
of the pancreatic remnant in the direction of the (a) anterior, (b) posterior, (c) 
superior, and (d) inferior cut edges. 
Table 1. Indication for pancreatic head resection
No. of Surgery
patients PPPD PD PHRSD DPPHR
Intraductal papillary mucinous neoplasm of the pancreas 29 15 3 7 4
Pancreatic ductal adenocarcinoma 27 19 8 0 0
Bile duct carcinoma 21 20 1 0 0
Ampullary carcinoma 7 5 1 1 0
Chronic pancreatitis 4 4 0 0 0
Endocrine tumor of the pancreas 2 0 0 1 1
Solid pseudopapillary tumor of the pancreas 2 2 0 0 0
Gallbladder carcinoma 2 1 1 0 0
Gastric carcinoma 1 0 1 0 0
PPPD: pylorus-preserving pancreaticoduodenectomy
PD: pancreaticoduodenectomy
PHRSD: pancreatic head resection with segmental duodenectomy
DPPHD: duodenum-preserving total pancreas head resection 
Table 2. Univariate analysis of perioperative risk factors for clinically relevant pancreatic fistula following pancreatic head resection
Clinically
Overall relevant fistula No fistulaa
Variables (n = 95) (n = 14) (n = 81) P value
Age (years) (mean ± SD) 68.9±9.7 66.3±9.8 69.4±9.5 0.219
Gender 0.142
  Male 51 10 (20) 41 (80)
  Female 44  4 (9) 40 (91)
History of jaundice 0.723
  Yes 31  4 (13) 27 (87)
  No 64 10 (16) 54 (84)
Laboratory values
  Lymphocyte (1000/mm3) 2.0±0.7 1.9±0.4 2.0±0.5 0.236
  Hemoglobin (g/dl) 12.5±07 12.8±0.6 12.3±0.4 0.581
  Albumin (g/dl) 3.8±0.8 3.7±0.7 3.8±0.6 0.769
  Total bilirubin (mg/dl) 1.5±1.9 1.6±1.7 1.5±1.4 0.734
  Creatinine clearance (ml/min) 68±20 66±18 69±16 0.292
Oral glucose tolerance test 0.334
  Normal 43  8 (19) 35 (81)
  Impaired, Diabetic 52 6 (12) 46 (88)
Hemoglobin A1c (%) 5.8±1.2 6.0±1.5 5.6±0.9 0.412
BT-PABA test (%) 60.7±14.0 67.5±12.9 59.5±13.8 0.032
TIC of the pancreas < 0.001
  Type I 66 14 (21) 52   (79)
  Type II, III 29 0   (0) 29 (100)
Pathology 0.291
  IPMN 29 4 (14) 25  (86)
  Pancreatic ductal adenocarcinoma 27 2   (7) 25  (93)
  Bile duct carcinoma 21 4 (19) 17  (81)
  Ampullary carcinoma 7 1 (14)  6  (86)
  Chronic pancreatitis 4 0   (0)  4 (100)
  Others 7 3 (43) 4  (57)
Texture of the pancreas 0.035
  Soft 52 11 (21) 41 (79)
  Intermediate 22 2  (9) 20 (91)
  Hard 21 1  (5) 20 (95)
Pancreatic duct size (mm) 0.023
  ≤3 57 12 (21) 45 (79)
  >3 38  2  (5) 36 (95)
Thickness of the pancreas (mm) 16.5±3.7 16.6±3.8 16.3±3.4 0.878
Width of the pancreas (mm) 28.1±5.6 28.3±6.3 27.9±5.5 0.866
Location of the pancreatic duct: 
  distance between the pancreatic duct and
  the cut edge of the pancreatic remnant (mm) 
  (a) to the anterior edge 9.1±2.6 10.3±3.1 8.7±2.4 0.121
  (b) to the posterior edge 4.1±1.7 3.3±1.9 4.3±1.7 0.041
  (c) to the superior edge 11.3±3.5 11.4±2.7 11.1±3.5 0.838
  (d) to the inferior edge 13.7±9.5 14.1±4.8 13.6±4.9 0.791
  (e) to the posterior edge 0.037
        ≤3mm 37 9 (24) 28 (76)
        >3mm 58  5 (9) 53 (91)
Type of pancreatic resection 0.571
  PPPD 66 10 (15) 56 (85)
  PD 15  3 (20) 12 (80)
  PHRSD 9 1 (11)  8  (89)
  DPPHR 5 0  (0)  5 (100)
Lymphadenectomy 0.961
  Non 6 1 (17)  5 (83)
  Regional 30 4 (13) 26 (87)
  Extended 59 9 (15) 50 (85)
Pancreaticojejunal anastomosis 0.036
  Transfixing suture 51 11 (22) 40 (78)
  Interrupted suture 44  3  (7) 41 (93)
Use of a pancreatic stent 0.209
  Yes 61 11 (18) 50 (82)
  No 34 3  (9) 31 (91)
Operative time (hours) 8.3±1.0 8.4±1.5 8.3±0.9 0.835
Blood loss (ml) 872±287 864±323 876±223 0.661
Blood transfusion 0.989
  With 27   4 (15) 23 (85)
  Without 68 10 (15) 58 (85)
Surgeon experience 0.913
  <15yrs 26   4 (15) 22 (85)
   ≥15yrs 69 10 (14) 59 (86)
a: No fistula indicates patients who lacked clinical evidence of fistula - no fistula or Grade A fistula
Values in parentheses are percentages of row totals.
BT-PABA: N-benzoyl-L-tyrosyl-p-aminobenzoic acid
TIC: time-signal intensity curve
IPMN: Intraductal papillary mucinous neoplasm of the pancreas
PPPD: pylorus-preserving pancreaticoduodenectomy 
PD: pancreaticoduodenectomy 
PHRSD :pancreatic head resection with segmental duodenectomy
DPPHR: duodenum-preserving total pancreatic head resection
Table 3. Multivariate analysis of perioperative risk factors for clinically relevant pancreatic fistula
following pancreatic head resection
Odds ratio
for clinically
Variables relevant fistula 95% CI p-value
BT-PABA test (%) 1.04 0.9-1.1 0.204
TIC of the pancreas
  Type II, III 1 -
  Type I 12.58 1.2-23.9 0.001
Texture of the pancreas
  Hard 1 -
  Intermediate 1.26 0.7-6.3 0.982
  Soft 4.67 1.2-51.1 0.006
Pancreatic duct size
  >3mm 1 -
  ≤3mm 4.05 0.4-40.3 0.186
Distance between the pancreatic duct and
the posterior cut edge of the pancreas 
  >3mm 1 -
  ≤3mm 1.31 0.2-7.0 0.748
Pancreaticojejunal anastomosis
  Interrupted suture 1 -
  Transfixing suture 9.91 1.7-57.5 0.003
BT-PABA: N-benzoyl-L-tyrosyl-p-aminobenzoic acid 
TIC: time-signal intensity curve
95% CI: 95% confidence intervals
Table 4. Univariate analysis of perioperative risk factors for clinically relevant pancreatic fistula following pancreatic head resection in comparison
between the transfixing suture group and the interrupted suture group
  Transfixing suture   Interrupted suture
Clinically Clinically
relevant fistula No fistulaa relevant fistula No fistulaa
Variables (n = 11) (n = 40) P value (n = 3) (n = 41) P value
BT-PABA test (%) 68.9±14.1 58.5±15.6 0.033 62.7±7.5 60.4±11.9 0.742
TIC of the pancreas 0.001 0.963
  Type I 11 (31) 24  (69)  3 (10) 28  (90)
  Type II, III 0   (0) 16 (100) 0  (0) 13(100)
Texture of the pancreas 0.001 0.628
  Soft 9 (41) 13 (59) 2  (7) 28  (93)
  Intermediate 1  (6) 16 (94) 1 (20)  4  (80)
  Hard 1  (8) 11 (92) 0  (0) 9(100)
Pancreatic duct size < 0.001 0.309
   ≤3mm 11 (37) 19  (63) 1  (4) 26 (96)
   >3mm  0   (0) 21(100) 2 (12) 15 (88)
Distance between the pancreatic duct and 0.001 0.079
  the posterior cut edge of the pancreas
   ≤3mm 9 (45)  11 (55) 0   (0) 17(100)
   >3mm 2  (6) 29 (94) 3 (12) 23  (88)
a: No fistula indicates patients who lacked clinical evidence of fistula - no fistula or Grade A fistula
Values in parentheses are percentages of row totals.
BT-PABA: N-benzoyl-L-tyrosyl-p-aminobenzoic acid
TIC: time-signal intensity curve









